Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.

MLA

Seridi, Loqmane, et al. “Novel Signatures Associated with Systemic Lupus Erythematosus Clinical Response to IFN-α/-ω Inhibition.” Lupus, vol. 30, no. 5, Apr. 2021, pp. 795–806. EBSCOhost, https://doi.org/10.1177/0961203321995576.

APA

Seridi, L., Cesaroni, M., Orillion, A., Schreiter, J., Chevrier, M., Marciniak, S., Migone, T.-S., Stohl, W., Chatham, W. W., Furie, R. A., Benson, J., & Jordan, J. (2021). Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. Lupus, 30(5), 795–806. https://doi.org/10.1177/0961203321995576

Chicago

Seridi, Loqmane, Matteo Cesaroni, Ashley Orillion, Jessica Schreiter, Marc Chevrier, Stanley Marciniak, Thi-Sau Migone, et al. 2021. “Novel Signatures Associated with Systemic Lupus Erythematosus Clinical Response to IFN-α/-ω Inhibition.” Lupus 30 (5): 795–806. doi:10.1177/0961203321995576.